6533b871fe1ef96bd12d0e50

RESEARCH PRODUCT

Dissection of C1q Capability of Interacting with IgG

Marcus KaulMichael Loos

subject

Serial dilutionElutionStereochemistryHuman immunodeficiency virus (HIV)chemical and pharmacologic phenomenaCell Biologyurologic and male genital diseasesmedicine.disease_causeBiochemistryLigand blottingchemistry.chemical_compoundfluids and secretionsImmune systemchemistryimmune system diseasesReagentmedicineUreaBiophysicsSodium dodecyl sulfateskin and connective tissue diseasesMolecular Biology

description

Abstract C1q-bearing immune complexes have been observed in diseases such as rheumatoid arthritis and human immunodeficiency virus infection-associated neuropathy. For the purpose of understanding better the phenomenon of C1q-bearing immune complexes, we investigated the constancy of the C1q-IgG interaction. An enzyme-linked immunosorbent assay was developed in which wells were coated with IgG to mimic antigen-complexed IgG. Serial dilutions of C1q were applied for distinct time intervals, and bound C1q was detected either directly or after exposure to one of several elution buffers. Our results show that a part of C1q attached to IgG forms a tight association that is not reversible under treatment with buffers containing usually protein-protein interaction-dissociating reagents such as 3m NaCl, 5 m urea, sodium dodecyl sulfate, or β-mercaptoethanol. The formation of the highly stable C1q-IgG complex was found to be time-, temperature-, and pH-dependent and to proceed with bound C1q even in the absence of free C1q in the supernatant. In ligand blotting experiments we demonstrate for the first time directly that all three chains of C1q can individually bind IgG. Altogether, our results provide a suitable explanation for the formation and persistence of C1q-bearing immune complexes.

https://doi.org/10.1074/jbc.272.52.33234